EPISODE · May 23, 2025 · 47 MIN
Joel Raskin, CMO of Arrivo Bio talks about unlocking the future of psychiatry
from Power to the Patients · host Brandon Li
Brandon Li talks with Joel Raskin, Chief Medical Officer at Arrivo, about his journey from training in psychiatry in Toronto to leading pharmaceutical research in his current role. Joel shares details on SP-624, an Arrivo compound showing promise in treating depression through epigenetic mechanisms. Their deep dive covers the challenges of clinical trials, and the potential for precision psychiatry to revolutionize psychiatry and neuroscience.
NOW PLAYING
Joel Raskin, CMO of Arrivo Bio talks about unlocking the future of psychiatry
No transcript for this episode yet
Similar Episodes
No similar episodes found.